Brief: Egetis Therapeutics Resolves On Rights Issue Of About SEK 180 Million

Egetis Therapeutics AB (publ)

21/03/2022 07:03

March 21 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS THERAPEUTICS RESOLVES ON A FULLY GUARANTEED
PREFERENTIAL
RIGHTS ISSUE OF APPROXIMATELY SEK 180 MILLION
    * SUBSCRIPTION PRICE HAS BEEN SET TO SEK 3.65 PER SHARE
    * ASSUMING THAT RIGHTS ISSUE IS FULLY SUBSCRIBED, AMOUNTS TO
ISSUE
PROCEEDS OF APPROXIMATELY SEK 180 MILLION BEFORE DEDUCTION OF
ISSUANCE COSTS
    * RIGHTS ISSUE COMPRISES A MAXIMUM OF 49,520,568 SHARES

Source text for Eikon:  ID:nMFN8pyLzn 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))